MedTrace Logo

Dispensing Study for the Phenacite Project

NCT02436005 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 25

Last updated 2020-11-18

Study results available
· View outcomes & findings →

Summary

Dispensing Study for the Phenacite Project.

The investigational test lens was not the final optical design and the study was not used for design validation.

Conditions

  • Ametropia

Interventions

DEVICE

Phenacite

Subjects will be randomized to wear the Phenacite contact lenses binocularly.

DEVICE

comfilcon A

Subjects will be randomized to wear the comfilcon A contact lenses binocularly.

Sponsors & Collaborators

  • CooperVision, Inc.

    lead INDUSTRY

Principal Investigators

  • Pete Kollbaun, OD PhD · CORL Indiana University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-04-30
Primary Completion
2015-07-31
Completion
2015-07-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02436005 on ClinicalTrials.gov